The primary goal of the combined University of Rochester (UR) - University at Buffalo (UB) Center's participation in the Eunice Kennedy Shriver NICHD Cooperative Multicenter Neonatal Research Network (NRN) is to improve the care of neonates through conceiving, developing, participating in, and completing large, well-designed interventional and observational trials that address important clinical questions.
The specific aims of this application to continue to achieve this goal are: 1. To continue contributions to critical and creative thinking, generating new ideas for clinical trials and their conduct; 2. To continue to participate fully in NRN trials by enrolling and retaining as many subjects as possible in a safe and ethical manner; and 3. To achieve a high level of follow-up, as this is critical to our testing of therapies in the neonate. To realize these aims, UR and UB will continue to participate as a combined Clinical Center with two performance sites (URUB). URUB provides proven enrollment, management and intellectual capabilities in the setting of strong academic clinical and basic science faculties with long-standing commitments to clinical trial excellence, large neonatal populations with high rates of recruitment and retention, excellent University and hospital support, experienced clinical research staff, established neonatal neurodevelopmental follow-up clinics, well-developed data systems, high-quality maternal-fetal medicine services, and strong obstetrical- neonatal communication. The URUB Center includes two geographically-adjacent NICUs, each with large neonatal populations, to increase subject availability, and draws on the intellectual excellence of two respected academic neonatal divisions. Center investigators have conceived and led several major NRN studies and contribute to every aspect of NRN planning and governance. The Center has consistently ranked in the top 35% of NRN centers for number of infants enrolled in clinical trials, and ranks 5th in size, as measured by enrollment in the generic database (GBD) of infants <29 weeks' gestation. URUB has achieved 100% follow- up of infants enrolled in NRN randomized controlled trials. This innovative application also contains proposals improve investigator training and to increase further the Center's capacity. The URUB Center has a strong record of involving young investigators in NRN activities. URUB will advance this effort by providing multi-faceted, formalized training for young investigators, to enable them to become the next generation of leaders in neonatal trials. The Center is also poised, if this application is successful, to expand the Center across upstate NY with the potential addition of Albany Medical Center. The intellectual, organizational and operational strengths detailed in this proposal will allow the URUB Clinical Center to continue to participate at the highest level in all aspects of the work of the NRN.

Public Health Relevance

The Neonatal Research Network is an excellent platform for conceiving and completing large, well-designed clinical trials, with recent randomized clinical trials in the areas of brain protection and lung disease in premature infants. The URUB Clinical Center has the leadership, enrollment and follow-up capabilities to continue to be an excellent venue for future, similar successes.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Clinical Research Cooperative Agreements - Single Project (UG1)
Project #
5UG1HD068263-07
Application #
9247897
Study Section
Special Emphasis Panel (ZHD1-DSR-A (50)R)
Program Officer
Raju, Tonse N
Project Start
2011-04-01
Project End
2021-03-31
Budget Start
2017-04-01
Budget End
2018-03-31
Support Year
7
Fiscal Year
2017
Total Cost
$204,684
Indirect Cost
$43,847
Name
University of Rochester
Department
Pediatrics
Type
Schools of Dentistry
DUNS #
041294109
City
Rochester
State
NY
Country
United States
Zip Code
14627
Lakshminrusimha, Satyan; Shankaran, Seetha; Laptook, Abbot et al. (2018) Pulmonary Hypertension Associated with Hypoxic-Ischemic Encephalopathy-Antecedent Characteristics and Comorbidities. J Pediatr 196:45-51.e3
Bajaj, Monika; Natarajan, Girija; Shankaran, Seetha et al. (2018) Delivery Room Resuscitation and Short-Term Outcomes in Moderately Preterm Infants. J Pediatr 195:33-38.e2
Laptook, Abbot R; Bell, Edward F; Shankaran, Seetha et al. (2018) Admission Temperature and Associated Mortality and Morbidity among Moderately and Extremely Preterm Infants. J Pediatr 192:53-59.e2
Meyers, J M; Tan, S; Bell, E F et al. (2018) Neurodevelopmental outcomes among extremely premature infants with linear growth restriction. J Perinatol :
Phelps, Dale L; Watterberg, Kristi L; Nolen, Tracy L et al. (2018) Effects of Myo-inositol on Type 1 Retinopathy of Prematurity Among Preterm Infants <28 Weeks' Gestational Age: A Randomized Clinical Trial. JAMA 320:1649-1658
D'Angio, C T; Wang, H; Hunn, J E et al. (2017) Permission form synopses to improve parents' understanding of research: a randomized trial. J Perinatol 37:735-739
Jensen, Erik A; Dysart, Kevin C; Gantz, Marie G et al. (2017) Association between Use of Prophylactic Indomethacin and the Risk for Bronchopulmonary Dysplasia in Extremely Preterm Infants. J Pediatr 186:34-40.e2
Walsh, Michele C; Bell, Edward F; Kandefer, Sarah et al. (2017) Neonatal outcomes of moderately preterm infants compared to extremely preterm infants. Pediatr Res 82:297-304
Vali, Payam; Lakshminrusimha, Satyan (2017) Case 2: Beware of Lumps and Bumps after Cooling! Neoreviews 18:e441-e444
James, Jennifer; Munson, David; DeMauro, Sara B et al. (2017) Outcomes of Preterm Infants following Discussions about Withdrawal or Withholding of Life Support. J Pediatr 190:118-123.e4

Showing the most recent 10 out of 18 publications